Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 28% ± 7% | |
| transit amplifying cell | 5 studies | 20% ± 3% | |
| goblet cell | 5 studies | 29% ± 8% | |
| Mueller cell | 3 studies | 26% ± 5% | |
| epithelial cell | 3 studies | 32% ± 7% | |
| intestinal crypt stem cell | 3 studies | 23% ± 6% | |
| oligodendrocyte | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of SNORC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 775.48 | 2637 / 2642 | 92% | 21.89 | 648 / 705 |
| liver | 88% | 248.22 | 198 / 226 | 89% | 21.51 | 363 / 406 |
| intestine | 50% | 198.53 | 480 / 966 | 90% | 14.37 | 474 / 527 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.81 | 1 / 1 |
| skin | 70% | 330.15 | 1275 / 1809 | 22% | 6.25 | 106 / 472 |
| stomach | 1% | 0.40 | 2 / 359 | 83% | 13.73 | 237 / 286 |
| breast | 52% | 287.47 | 239 / 459 | 31% | 4.94 | 346 / 1118 |
| ovary | 2% | 1.54 | 3 / 180 | 77% | 5.13 | 332 / 430 |
| kidney | 28% | 25.45 | 25 / 89 | 37% | 1.78 | 333 / 901 |
| prostate | 40% | 33.01 | 98 / 245 | 19% | 0.61 | 96 / 502 |
| esophagus | 5% | 4.22 | 79 / 1445 | 50% | 4.13 | 92 / 183 |
| pancreas | 4% | 3.16 | 13 / 328 | 48% | 2.84 | 85 / 178 |
| bladder | 5% | 3.62 | 1 / 21 | 45% | 5.91 | 227 / 504 |
| lung | 3% | 4.17 | 18 / 578 | 28% | 1.70 | 324 / 1155 |
| uterus | 4% | 2.99 | 7 / 170 | 26% | 1.37 | 118 / 459 |
| eye | 0% | 0 | 0 / 0 | 25% | 1.32 | 20 / 80 |
| thymus | 2% | 1.78 | 14 / 653 | 19% | 0.65 | 114 / 605 |
| adrenal gland | 10% | 7.51 | 26 / 258 | 10% | 0.30 | 22 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 1.36 | 5 / 29 |
| peripheral blood | 15% | 16.79 | 142 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.30 | 5 / 45 |
| spleen | 10% | 7.20 | 23 / 241 | 0% | 0 | 0 / 0 |
| adipose | 3% | 8.34 | 39 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 3% | 2.65 | 24 / 803 | 0% | 0 | 0 / 0 |
| heart | 1% | 0.78 | 8 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 0.92 | 12 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051216 | Biological process | cartilage development |
| GO_0071944 | Cellular component | cell periphery |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SNORC |
| Protein name | Secondary ossification center associated regulator of chondrocyte maturation Protein SNORC Protein SNORC (Secondary ossification center-associated regulator of chondrocyte maturation protein) |
| Synonyms | ASCL830 C2orf82 UNQ830 UNQ830/PRO1757 |
| Description | FUNCTION: Plays a role in the regulation of chondrocyte maturation and postnatal endochondral ossification. May inhibit cell growth stimulation induced by FGF2. . |
| Accessions | Q6UX34 A0A6M4NK13 ENST00000448993.1 ENST00000409533.5 C9K0N5 ENST00000409230.5 ENST00000695538.1 ENST00000331342.5 |
